跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目9051-9100 / 12972. (共260頁) << < 177 178 179 180 181 182 183 184 185 186 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2017-03-30	Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome	PLoS ONE. 2017 Mar 30;12(3):Article number e0174647.
2014-03-26	Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats as measured by dynamic contrast-enhanced MRI	PLoS ONE. 2014 Mar 26;9(3):Article number e92910.
2019-03	Pharmacokinetic study of amoxicillin in Japanese eel Anguilla japonica by high performance liquid chromatography with fluorescence detection	Aquaculture Reports. 2019 Mar;13:Article number 100184.
2018-10-01	Pharmacokinetic study of florfenicol in Bester sturgeon, a cultured hybrid of Huso huso × Acipenser ruthenus by high performance liquid chromatography equipped with UV detector	Aquaculture. 2018 Oct 1;495:558-567.
2011-05	Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214	Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73.
2016-12	Pharmacokinetics and bioavailability of oral single-dose maleic acid in biofluids of Sprague-Dawley rats	Drug Metabolism and Pharmacokinetics. 2016 Dec;31(6):451-457.
2011-06	Pharmacokinetics and dosimetry of (111)In/(188)relabeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models	Cancer Biotherapy and Radiopharmaceuticals. 2011 Jun;26(3):373-380.
2010-12	Pharmacokinetics and physiologically-based pharmacokinetic modeling of nanoparticles	Journal of Nanoscience and Nanotechnology. 2010 Dec;10(12):8482-8490.
2006-12	Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats	Journal of Food and Drug Analysis. 2006 Dec;14(4):329-333.
2008-11	Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice model	Nuclear Medicine and Biology. 2008 Nov;35(8):883-893.
2013-08-01	Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression	Cell. 2013 Aug 1;154(3):556-568.
2015-07	Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells	Molecular and Cellular Biology. 2015 Jul;35(14):2541-2553.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
2013-10-11	Pharmacological profiles of oligomerized mu-opioid receptors	Cells. 2013 Oct 11;2(4):689-714.
2020-04	Pharmacological studies of morphine in a novel humanized mu opioid receptor mouse model	FASEB Journal. 2020 Apr;34(S1):Abstract number 02835.
2022-11-17	Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan	Computational and Structural Biotechnology Journal. 2022 Nov 17;20:6458-6466.
2017-12-28	Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection	BMC Bioinformatics. 2017 Dec 28;18(Suppl. 16):Article number 548.
2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2022-02-01	A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378.
2017-09	A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02)	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 617O.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.
2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
1997-07	A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions	Anti-Cancer Drugs. 1997 Jul;8(6):565-573.
2013-12	Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma	Journal of Hepatology. 2013 Dec;59(6):1271-1277.
2021-05	Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia	Cancer Medicine. 2021 May;10(9):2946-2955.
2020-05	Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in patients with pretreated biliary tract cancer	Journal for ImmunoTherapy of Cancer. 2020 May;8(1):Article number e00056.
2021-07	A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers	Annals of Oncology. 2021 Jul;32(Suppl. 3):S146-S147.
2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879.
2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	Journal of Clinical Oncology. 2012 Feb;30(4):613.
2021-05	Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 4090.
2010-05	Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors	Journal of Clinical Oncology. 2010 May;28(15):Abstract Number e13024.
2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
2002	A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer	Oncology. 2002;63(3):239-247.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2013-05	A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine	Vaccine. 2013 May;31(20):2471-2476.
2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 Mar;21(3):531-536.
2008-05	Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma	Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610.
2018-05	A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers	Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556.
2011-08-17	A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan	Cancer Chemotherapy and Pharmacology. 2011 Aug 17;67(6):1281-1289.
2002-05	Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients	Cancer Chemotherapy and Pharmacology. 2002 May;49(5):425-428.
2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	Oncology. 2014 Jul;87(2):104-113.
2007-05	Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy	Cancer. 2007 May;109(9):1821-1828.
2006-02	A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Journal of Thoracic Oncology. 2006 Feb;1(2):141-145.
2008-08	A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Lung Cancer. 2008 Aug;61(2):214-219.

顯示項目9051-9100 / 12972. (共260頁) << < 177 178 179 180 181 182 183 184 185 186 > >> 每頁顯示[10|25|50]項目